SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1TA'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_A_STRA1_1 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 10 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ARG A 80MET A 115CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.45A | 1a28A-5ufsA:37.7 | 1a28A-5ufsA:58.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A28_B_STRB2_1 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ARG A 80MET A 115CYH A 205THR A 208 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A) | 0.51A | 1a28B-5ufsA:37.2 | 1a28B-5ufsA:58.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1G50_B_ESTB1600_1 (ESTROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | MET A 29LEU A 32LEU A 77ARG A 80MET A 108 | 1TA A 301 ( 2.9A)1TA A 301 (-3.5A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A) | 1.01A | 1g50B-5ufsA:27.4 | 1g50B-5ufsA:30.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1GS4_A_ZK5A1918_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | ASN A 33GLY A 37GLN A 39TRP A 69MET A 70PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-4.0A) | 1.29A | 1gs4A-5ufsA:35.3 | 1gs4A-5ufsA:55.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1GS4_A_ZK5A1918_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | LEU A 32ASN A 33LEU A 35GLY A 36GLN A 39MET A 108PHE A 218 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.0A)1TA A 301 (-4.0A) | 0.89A | 1gs4A-5ufsA:35.3 | 1gs4A-5ufsA:55.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1GS4_A_ZK5A1918_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLY A 36GLN A 39TRP A 69MET A 70PHE A 218 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-4.0A) | 0.75A | 1gs4A-5ufsA:35.3 | 1gs4A-5ufsA:55.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 11 / 12 | ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80MET A 115CYH A 205THR A 208PHE A 218LEU A 222 | 1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A)None | 0.48A | 1m2zA-5ufsA:38.8 | 1m2zA-5ufsA:77.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | ASN A 33GLY A 37GLN A 39TRP A 69MET A 70CYH A 205THR A 208PHE A 218LEU A 222 | 1TA A 301 (-3.0A)None1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A)None | 0.92A | 1m2zA-5ufsA:38.8 | 1m2zA-5ufsA:77.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_A_DEXA301_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 11 / 12 | MET A 29ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80CYH A 205THR A 208PHE A 218LEU A 222 | 1TA A 301 ( 2.9A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A)None | 0.47A | 1m2zA-5ufsA:38.8 | 1m2zA-5ufsA:77.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | ASN A 33GLY A 37GLN A 39MET A 70CYH A 205THR A 208PHE A 218LEU A 222 | 1TA A 301 (-3.0A)None1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A)None | 0.93A | 1m2zD-5ufsA:38.6 | 1m2zD-5ufsA:77.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1M2Z_D_DEXD401_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 11 / 12 | MET A 29ASN A 33GLY A 36GLN A 39MET A 70ARG A 80MET A 115CYH A 205THR A 208PHE A 218LEU A 222 | 1TA A 301 ( 2.9A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A)None | 0.53A | 1m2zD-5ufsA:38.6 | 1m2zD-5ufsA:77.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39VAL A 40ARG A 80 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 (-3.5A) | 0.93A | 1nhzA-5ufsA:31.9 | 1nhzA-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | LEU A 32GLY A 36GLN A 39VAL A 40MET A 73LEU A 77ARG A 80MET A 115LEU A 201 | 1TA A 301 (-3.5A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 (-4.2A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A) | 0.58A | 1nhzA-5ufsA:31.9 | 1nhzA-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | VAL A 40MET A 73LEU A 77ARG A 80GLN A 111MET A 115 | None1TA A 301 (-4.2A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)None1TA A 301 ( 2.8A) | 1.31A | 1nhzA-5ufsA:31.9 | 1nhzA-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | LEU A 32ASN A 33LEU A 35GLY A 36GLN A 39MET A 70ARG A 80MET A 115THR A 208 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.0A) | 0.59A | 1p93A-5ufsA:37.0 | 1p93A-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_A_DEXA1999_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | MET A 29ASN A 33GLY A 36GLN A 39MET A 70 | 1TA A 301 ( 2.9A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A) | 0.79A | 1p93A-5ufsA:37.0 | 1p93A-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 10 / 12 | ASN A 33GLY A 36GLN A 39MET A 70LEU A 77ARG A 80MET A 115CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.45A | 1p93B-5ufsA:37.1 | 1p93B-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.02A | 1p93B-5ufsA:37.1 | 1p93B-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_B_DEXB2999_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | MET A 29ASN A 33GLY A 36MET A 70CYH A 205PHE A 218 | 1TA A 301 ( 2.9A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 ( 3.1A)1TA A 301 (-3.6A)1TA A 301 (-4.0A) | 0.80A | 1p93B-5ufsA:37.1 | 1p93B-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 10 / 12 | ASN A 33GLY A 36GLN A 39MET A 70LEU A 77ARG A 80MET A 115LEU A 201CYH A 205THR A 208 | 1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A) | 0.62A | 1p93C-5ufsA:36.7 | 1p93C-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208 | 1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.6A)1TA A 301 (-3.0A) | 1.11A | 1p93C-5ufsA:36.7 | 1p93C-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | GLN A 39MET A 70LEU A 77ARG A 80GLN A 111MET A 115CYH A 205 | 1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)None1TA A 301 ( 2.8A)1TA A 301 (-3.6A) | 1.42A | 1p93C-5ufsA:36.7 | 1p93C-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_C_DEXC3999_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | MET A 29ASN A 33GLY A 36MET A 70LEU A 201CYH A 205 | 1TA A 301 ( 2.9A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 ( 3.1A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A) | 0.88A | 1p93C-5ufsA:36.7 | 1p93C-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 10 / 12 | ASN A 33GLY A 36GLN A 39MET A 70ARG A 80PHE A 92MET A 115CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 (-4.4A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.56A | 1p93D-5ufsA:36.8 | 1p93D-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.05A | 1p93D-5ufsA:36.8 | 1p93D-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | MET A 29ASN A 33GLY A 36GLN A 39MET A 70CYH A 205PHE A 218 | 1TA A 301 ( 2.9A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.6A)1TA A 301 (-4.0A) | 0.72A | 1p93D-5ufsA:36.8 | 1p93D-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 4 / 5 | LEU A 32TRP A 69MET A 73LEU A 77 | 1TA A 301 (-3.5A)None1TA A 301 (-4.2A)1TA A 301 ( 3.4A) | 0.43A | 1p93D-5ufsA:36.8 | 1p93D-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1P93_D_DEXD4999_2 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 4 / 5 | TRP A 69MET A 73LEU A 77GLN A 111 | None1TA A 301 (-4.2A)1TA A 301 ( 3.4A)None | 1.17A | 1p93D-5ufsA:36.8 | 1p93D-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 73MET A 115 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 ( 2.8A) | 0.80A | 1sqnA-5ufsA:37.2 | 1sqnA-5ufsA:56.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 115CYH A 205 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A) | 0.48A | 1sqnA-5ufsA:37.2 | 1sqnA-5ufsA:56.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 115LEU A 201CYH A 205 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A) | 0.52A | 1sqnB-5ufsA:37.1 | 1sqnB-5ufsA:56.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | LEU A 32LEU A 35GLN A 39MET A 70MET A 73MET A 115LEU A 201 | 1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A) | 0.86A | 1sqnB-5ufsA:37.1 | 1sqnB-5ufsA:56.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | LEU A 35MET A 108LEU A 77MET A 115LEU A 90 | 1TA A 301 ( 3.6A)1TA A 301 ( 3.0A)1TA A 301 ( 3.4A)1TA A 301 ( 2.8A)None | 0.89A | 1sqnB-5ufsA:37.1 | 1sqnB-5ufsA:56.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_A_STRA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | ASN A 33LEU A 35GLN A 39LEU A 77ARG A 80MET A 108MET A 115THR A 208 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 ( 2.8A)1TA A 301 (-3.0A) | 1.01A | 1ya3A-5ufsA:35.5 | 1ya3A-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_A_STRA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80MET A 115CYH A 205THR A 208 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A) | 0.46A | 1ya3A-5ufsA:35.5 | 1ya3A-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_A_STRA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | LEU A 28LEU A 35GLN A 39LEU A 77ARG A 80MET A 108MET A 115 | None1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 ( 2.8A) | 1.44A | 1ya3A-5ufsA:35.5 | 1ya3A-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_B_STRB2001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | ASN A 33GLN A 39MET A 70LEU A 77ARG A 80LEU A 201CYH A 205THR A 208 | 1TA A 301 (-3.0A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A) | 0.38A | 1ya3B-5ufsA:35.4 | 1ya3B-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_B_STRB2001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33LEU A 90LEU A 201CYH A 205THR A 208 | 1TA A 301 (-3.0A)None1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A) | 1.28A | 1ya3B-5ufsA:35.4 | 1ya3B-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_C_STRC3001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | LEU A 32ASN A 33LEU A 35ARG A 80MET A 108THR A 208 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 (-3.0A) | 1.12A | 1ya3C-5ufsA:35.3 | 1ya3C-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YA3_C_STRC3001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ARG A 80LEU A 201CYH A 205THR A 208 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A) | 0.40A | 1ya3C-5ufsA:35.3 | 1ya3C-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z95_A_198A501_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | GLY A 37GLN A 39MET A 70MET A 73ARG A 80ILE A 226 | None1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A)None | 1.08A | 1z95A-5ufsA:34.5 | 1z95A-5ufsA:55.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Z95_A_198A501_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | LEU A 35GLY A 36GLN A 39MET A 70MET A 73ARG A 80ILE A 226 | 1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A)None | 0.83A | 1z95A-5ufsA:34.5 | 1z95A-5ufsA:55.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_A_T98A201_1 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 10 | ASN A 33GLN A 39LEU A 77ARG A 80THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-3.0A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.48A | 1zucA-5ufsA:37.6 | 1zucA-5ufsA:57.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80THR A 208PHE A 218 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.68A | 1zucB-5ufsA:37.0 | 1zucB-5ufsA:57.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | LEU A 32ASN A 33LEU A 90THR A 208PHE A 218 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)None1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.28A | 1zucB-5ufsA:37.0 | 1zucB-5ufsA:57.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | LEU A 35GLN A 39MET A 73LEU A 77ARG A 80 | 1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.2A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A) | 0.96A | 1zucB-5ufsA:37.0 | 1zucB-5ufsA:57.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_A_STRA301_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | ASN A 33LEU A 35GLN A 39LEU A 77ARG A 80MET A 108THR A 208 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 (-3.0A) | 1.07A | 2aa5A-5ufsA:36.4 | 2aa5A-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_A_STRA301_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80MET A 115CYH A 205THR A 208 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A) | 0.49A | 2aa5A-5ufsA:36.4 | 2aa5A-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_B_STRB302_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33LEU A 35ARG A 80MET A 108THR A 208 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 (-3.0A) | 1.06A | 2aa5B-5ufsA:36.5 | 2aa5B-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA5_B_STRB302_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80CYH A 205THR A 208 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 (-3.6A)1TA A 301 (-3.0A) | 0.41A | 2aa5B-5ufsA:36.5 | 2aa5B-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA6_A_STRA401_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39LEU A 77ARG A 80MET A 108THR A 208 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 (-3.0A) | 0.92A | 2aa6A-5ufsA:36.8 | 2aa6A-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA6_A_STRA401_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 10 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80MET A 115CYH A 205THR A 208 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A) | 0.40A | 2aa6A-5ufsA:36.8 | 2aa6A-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA6_B_STRB402_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33LEU A 35ARG A 80MET A 108THR A 208 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 (-3.0A) | 0.97A | 2aa6B-5ufsA:36.6 | 2aa6B-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AA6_B_STRB402_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 10 / 12 | ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80MET A 115LEU A 201CYH A 205THR A 208 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A) | 0.43A | 2aa6B-5ufsA:36.6 | 2aa6B-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_A_SNLA502_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | ASN A 33GLN A 39ARG A 80PHE A 92MET A 108THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 (-4.4A)1TA A 301 ( 3.0A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.09A | 2ab2A-5ufsA:36.7 | 2ab2A-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_A_SNLA502_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | ASN A 33GLN A 39MET A 70ARG A 80PHE A 92MET A 115CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 (-4.4A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.53A | 2ab2A-5ufsA:36.7 | 2ab2A-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_A_SNLA502_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | LEU A 28GLN A 39ARG A 80PHE A 92MET A 115 | None1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 (-4.4A)1TA A 301 ( 2.8A) | 1.49A | 2ab2A-5ufsA:36.7 | 2ab2A-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_A_SNLA502_2 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 6 | LEU A 32LEU A 35LEU A 77CYH A 112LEU A 201 | 1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 ( 3.4A)1TA A 301 ( 3.6A)1TA A 301 ( 3.8A) | 0.40A | 2ab2A-5ufsA:36.7 | 2ab2A-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | ASN A 33GLN A 39ARG A 80PHE A 92MET A 108THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 (-4.4A)1TA A 301 ( 3.0A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.09A | 2ab2B-5ufsA:36.5 | 2ab2B-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | ASN A 33GLN A 39MET A 70ARG A 80PHE A 92MET A 115CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 (-4.4A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.55A | 2ab2B-5ufsA:36.5 | 2ab2B-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | LEU A 28GLN A 39ARG A 80PHE A 92MET A 115 | None1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 (-4.4A)1TA A 301 ( 2.8A) | 1.48A | 2ab2B-5ufsA:36.5 | 2ab2B-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AB2_B_SNLB503_2 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 4 / 5 | LEU A 32LEU A 35LEU A 77CYH A 112 | 1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 ( 3.4A)1TA A 301 ( 3.6A) | 0.30A | 2ab2B-5ufsA:36.5 | 2ab2B-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AM9_A_TESA1000_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | ASN A 33LEU A 35TRP A 69MET A 70MET A 73ARG A 80 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)None1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A) | 0.83A | 2am9A-5ufsA:35.8 | 2am9A-5ufsA:52.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AM9_A_TESA1000_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | ASN A 33TRP A 69MET A 70MET A 73ARG A 80LEU A 201 | 1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A)1TA A 301 ( 3.8A) | 0.82A | 2am9A-5ufsA:35.8 | 2am9A-5ufsA:52.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AM9_A_TESA1000_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | GLN A 39TRP A 69MET A 70MET A 73ARG A 80LEU A 201 | 1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A)1TA A 301 ( 3.8A) | 0.98A | 2am9A-5ufsA:35.8 | 2am9A-5ufsA:52.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AM9_A_TESA1000_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | LEU A 35GLN A 39TRP A 69MET A 70MET A 73ARG A 80 | 1TA A 301 ( 3.6A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A) | 1.04A | 2am9A-5ufsA:35.8 | 2am9A-5ufsA:52.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | ASN A 33LEU A 35GLN A 39LEU A 77ARG A 80MET A 108THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.05A | 2oaxA-5ufsA:35.2 | 2oaxA-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 10 / 12 | ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80LEU A 201CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.53A | 2oaxA-5ufsA:35.2 | 2oaxA-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | ASN A 33LEU A 90LEU A 201CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.18A | 2oaxA-5ufsA:35.2 | 2oaxA-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_B_SNLB2001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 10 / 12 | ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80LEU A 201CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.45A | 2oaxB-5ufsA:35.3 | 2oaxB-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_B_SNLB2001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33LEU A 90CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.15A | 2oaxB-5ufsA:35.3 | 2oaxB-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_C_SNLC3001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | ASN A 33GLN A 39LEU A 77ARG A 80MET A 108THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-3.0A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.16A | 2oaxC-5ufsA:34.4 | 2oaxC-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_C_SNLC3001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | ASN A 33GLN A 39TRP A 69MET A 70LEU A 77ARG A 80LEU A 201THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.8A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.46A | 2oaxC-5ufsA:34.4 | 2oaxC-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_C_SNLC3001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33LEU A 90LEU A 201THR A 208PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 ( 3.8A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.27A | 2oaxC-5ufsA:34.4 | 2oaxC-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_D_SNLD4001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | ASN A 33LEU A 35GLN A 39LEU A 77ARG A 80MET A 108PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 (-4.0A) | 1.10A | 2oaxD-5ufsA:35.8 | 2oaxD-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_D_SNLD4001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | ASN A 33LEU A 35GLN A 39TRP A 69MET A 70LEU A 77ARG A 80LEU A 201PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.8A)1TA A 301 (-4.0A) | 0.48A | 2oaxD-5ufsA:35.8 | 2oaxD-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_E_SNLE5001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | ASN A 33LEU A 35GLN A 39ARG A 80MET A 108PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 (-4.0A) | 1.00A | 2oaxE-5ufsA:35.6 | 2oaxE-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_E_SNLE5001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80LEU A 201CYH A 205PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-4.0A) | 0.57A | 2oaxE-5ufsA:35.6 | 2oaxE-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_E_SNLE5001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33LEU A 90LEU A 201CYH A 205PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-4.0A) | 1.13A | 2oaxE-5ufsA:35.6 | 2oaxE-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_F_SNLF6001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 11 / 12 | ASN A 33LEU A 35GLN A 39TRP A 69MET A 70LEU A 77ARG A 80LEU A 201CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.52A | 2oaxF-5ufsA:35.7 | 2oaxF-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OAX_F_SNLF6001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33LEU A 90CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.13A | 2oaxF-5ufsA:35.7 | 2oaxF-5ufsA:62.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLY A 36GLN A 39ARG A 80MET A 108PHE A 218 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 (-4.0A) | 1.09A | 2oz7A-5ufsA:34.4 | 2oz7A-5ufsA:54.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_2 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 4 / 6 | MET A 70MET A 73MET A 115LEU A 201 | 1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A) | 0.83A | 2oz7A-5ufsA:34.4 | 2oz7A-5ufsA:54.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OZ7_A_CA4A1_2 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 4 / 6 | TRP A 69MET A 70MET A 115LEU A 201 | None1TA A 301 ( 3.1A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A) | 1.35A | 2oz7A-5ufsA:34.4 | 2oz7A-5ufsA:54.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7I_A_TESA205_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39ARG A 80MET A 108 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A) | 1.07A | 2q7iA-5ufsA:34.9 | 2q7iA-5ufsA:53.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7I_A_TESA205_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 73ARG A 80 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A) | 0.84A | 2q7iA-5ufsA:34.9 | 2q7iA-5ufsA:53.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7J_A_TESA203_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33LEU A 35GLN A 39ARG A 80MET A 108 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A) | 1.17A | 2q7jA-5ufsA:35.6 | 2q7jA-5ufsA:53.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7J_A_TESA203_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | ASN A 33LEU A 35GLN A 39TRP A 69MET A 70MET A 73ARG A 80 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A) | 0.85A | 2q7jA-5ufsA:35.6 | 2q7jA-5ufsA:53.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7J_A_TESA203_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | LEU A 28LEU A 35GLN A 39ARG A 80MET A 108 | None1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A) | 1.47A | 2q7jA-5ufsA:35.6 | 2q7jA-5ufsA:53.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7K_A_TESA304_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33GLN A 39MET A 70ARG A 80LEU A 201 | 1TA A 301 (-3.0A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 3.8A) | 0.70A | 2q7kA-5ufsA:35.1 | 2q7kA-5ufsA:53.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7K_A_TESA304_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39ARG A 80MET A 108 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A) | 1.05A | 2q7kA-5ufsA:35.1 | 2q7kA-5ufsA:53.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7K_A_TESA304_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ARG A 80 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A) | 0.75A | 2q7kA-5ufsA:35.1 | 2q7kA-5ufsA:53.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7L_A_TESA155_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33GLY A 37GLN A 39TRP A 69MET A 70 | 1TA A 301 (-3.0A)None1TA A 301 (-3.0A)None1TA A 301 ( 3.1A) | 1.30A | 2q7lA-5ufsA:35.5 | 2q7lA-5ufsA:53.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7L_A_TESA155_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | LEU A 32ASN A 33LEU A 35GLY A 36GLN A 39ARG A 80MET A 108 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A) | 1.02A | 2q7lA-5ufsA:35.5 | 2q7lA-5ufsA:53.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Q7L_A_TESA155_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLY A 36GLN A 39TRP A 69MET A 70ARG A 80 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.5A) | 0.73A | 2q7lA-5ufsA:35.5 | 2q7lA-5ufsA:53.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | GLY A 37GLN A 39TRP A 69MET A 70CYH A 205 | None1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.6A) | 1.04A | 2w8yA-5ufsA:37.1 | 2w8yA-5ufsA:57.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | LEU A 35GLY A 36GLN A 39TRP A 69MET A 70ARG A 80CYH A 205 | 1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 (-3.6A) | 0.42A | 2w8yA-5ufsA:37.1 | 2w8yA-5ufsA:57.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | LEU A 35GLY A 36GLN A 39TRP A 69MET A 70MET A 73ARG A 80 | 1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A) | 0.79A | 2w8yA-5ufsA:37.1 | 2w8yA-5ufsA:57.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ARG A 80MET A 115CYH A 205 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A) | 0.53A | 2w8yB-5ufsA:37.6 | 2w8yB-5ufsA:57.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70MET A 73ARG A 80MET A 115 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A) | 0.79A | 2w8yB-5ufsA:37.6 | 2w8yB-5ufsA:57.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YHD_A_TESA1920_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33GLY A 37GLN A 39MET A 70MET A 73 | 1TA A 301 (-3.0A)None1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A) | 1.43A | 2yhdA-5ufsA:35.1 | 2yhdA-5ufsA:54.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YHD_A_TESA1920_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | ASN A 33LEU A 35GLY A 36GLN A 39ARG A 80MET A 108 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A) | 1.04A | 2yhdA-5ufsA:35.1 | 2yhdA-5ufsA:54.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YHD_A_TESA1920_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | ASN A 33LEU A 35GLY A 36GLN A 39MET A 70MET A 73ARG A 80 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A) | 0.79A | 2yhdA-5ufsA:35.1 | 2yhdA-5ufsA:54.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLO_A_TESA1920_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | LEU A 32ASN A 33LEU A 35MET A 70MET A 73ARG A 80PHE A 218 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A)1TA A 301 (-4.0A) | 0.89A | 2yloA-5ufsA:35.2 | 2yloA-5ufsA:54.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLO_A_TESA1920_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | LEU A 35GLN A 39MET A 70MET A 73ARG A 80 | 1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A) | 1.01A | 2yloA-5ufsA:35.2 | 2yloA-5ufsA:54.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLP_A_TESA1921_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 11 | ASN A 33GLN A 39MET A 70MET A 73ARG A 80LEU A 201 | 1TA A 301 (-3.0A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A)1TA A 301 ( 3.8A) | 0.82A | 2ylpA-5ufsA:35.5 | 2ylpA-5ufsA:54.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLP_A_TESA1921_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 11 | ASN A 33LEU A 35GLN A 39MET A 70MET A 73ARG A 80 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A) | 0.85A | 2ylpA-5ufsA:35.5 | 2ylpA-5ufsA:54.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2YLQ_A_TESA1921_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 11 | ASN A 33LEU A 35GLN A 39MET A 70MET A 73ARG A 80 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A) | 0.84A | 2ylqA-5ufsA:35.5 | 2ylqA-5ufsA:54.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | ASN A 33GLY A 37GLN A 39MET A 70CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.07A | 3cldA-5ufsA:38.2 | 3cldA-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 12 / 12 | MET A 29ASN A 33GLY A 36GLN A 39MET A 70LEU A 77ARG A 80CYH A 112LEU A 201CYH A 205THR A 208PHE A 218 | 1TA A 301 ( 2.9A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.41A | 3cldA-5ufsA:38.2 | 3cldA-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | MET A 29ASN A 33LEU A 90CYH A 205THR A 208PHE A 218 | 1TA A 301 ( 2.9A)1TA A 301 (-3.0A)None1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.31A | 3cldA-5ufsA:38.2 | 3cldA-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_2 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 9 | LEU A 32LEU A 35MET A 73ALA A 74MET A 108MET A 115 | 1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 (-4.2A)1TA A 301 ( 3.7A)1TA A 301 ( 3.0A)1TA A 301 ( 2.8A) | 0.74A | 3cldA-5ufsA:38.2 | 3cldA-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_2 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 9 | LEU A 32LEU A 35MET A 73MET A 108GLN A 111MET A 115 | 1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 (-4.2A)1TA A 301 ( 3.0A)None1TA A 301 ( 2.8A) | 0.84A | 3cldA-5ufsA:38.2 | 3cldA-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_2 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 9 | LEU A 32LEU A 35TRP A 69MET A 73ALA A 74MET A 115 | 1TA A 301 (-3.5A)1TA A 301 ( 3.6A)None1TA A 301 (-4.2A)1TA A 301 ( 3.7A)1TA A 301 ( 2.8A) | 0.36A | 3cldA-5ufsA:38.2 | 3cldA-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_A_GW6A1_2 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 9 | LEU A 32LEU A 35TRP A 69MET A 73GLN A 111MET A 115 | 1TA A 301 (-3.5A)1TA A 301 ( 3.6A)None1TA A 301 (-4.2A)None1TA A 301 ( 2.8A) | 0.65A | 3cldA-5ufsA:38.2 | 3cldA-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.94A | 3cldB-5ufsA:38.3 | 3cldB-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 11 / 12 | MET A 29ASN A 33GLY A 36GLN A 39MET A 70ARG A 80CYH A 112LEU A 201CYH A 205THR A 208PHE A 218 | 1TA A 301 ( 2.9A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.45A | 3cldB-5ufsA:38.3 | 3cldB-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | MET A 29GLY A 36GLN A 39ARG A 80MET A 108CYH A 112LEU A 201 | 1TA A 301 ( 2.9A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 ( 3.6A)1TA A 301 ( 3.8A) | 0.80A | 3cldB-5ufsA:38.3 | 3cldB-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_2 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 8 | LEU A 32MET A 73ALA A 74LEU A 77MET A 115 | 1TA A 301 (-3.5A)1TA A 301 (-4.2A)1TA A 301 ( 3.7A)1TA A 301 ( 3.4A)1TA A 301 ( 2.8A) | 0.40A | 3cldB-5ufsA:38.3 | 3cldB-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CLD_B_GW6B2_2 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 8 | LEU A 32MET A 73LEU A 77GLN A 111MET A 115 | 1TA A 301 (-3.5A)1TA A 301 (-4.2A)1TA A 301 ( 3.4A)None1TA A 301 ( 2.8A) | 0.53A | 3cldB-5ufsA:38.3 | 3cldB-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | ASN A 33LEU A 35GLN A 39MET A 70MET A 73ARG A 80MET A 115 | 1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A) | 0.91A | 3d90A-5ufsA:36.5 | 3d90A-5ufsA:57.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ARG A 80MET A 115CYH A 205 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A) | 0.60A | 3d90A-5ufsA:36.5 | 3d90A-5ufsA:57.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3D90_B_NOGB2001_1 (PROGESTERONERECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70LEU A 77ARG A 80MET A 115CYH A 205 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A) | 0.67A | 3d90B-5ufsA:36.4 | 3d90B-5ufsA:57.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ERD_A_DESA600_1 (ESTROGEN RECEPTORALPHA) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | MET A 29LEU A 32LEU A 77ARG A 80MET A 108 | 1TA A 301 ( 2.9A)1TA A 301 (-3.5A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A) | 1.19A | 3erdA-5ufsA:27.9 | 3erdA-5ufsA:29.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ERD_A_DESA600_1 (ESTROGEN RECEPTORALPHA) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | MET A 29LEU A 32LEU A 201LEU A 77ARG A 80 | 1TA A 301 ( 2.9A)1TA A 301 (-3.5A)1TA A 301 ( 3.8A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A) | 1.17A | 3erdA-5ufsA:27.9 | 3erdA-5ufsA:29.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | ASN A 33GLY A 37TRP A 69MET A 70CYH A 205THR A 208VAL A 216 | 1TA A 301 (-3.0A)NoneNone1TA A 301 ( 3.1A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.3A) | 0.84A | 3gn8A-5ufsA:40.5 | 3gn8A-5ufsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 11 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80MET A 115CYH A 205THR A 208VAL A 216 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.3A) | 0.44A | 3gn8A-5ufsA:40.5 | 3gn8A-5ufsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_A_DEXA247_1 (GLUCOCORTICOIDRECEPTOR 2) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | TRP A 69MET A 70ARG A 80GLN A 111MET A 115CYH A 205 | None1TA A 301 ( 3.1A)1TA A 301 (-3.5A)None1TA A 301 ( 2.8A)1TA A 301 (-3.6A) | 1.37A | 3gn8A-5ufsA:40.5 | 3gn8A-5ufsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | ASN A 33GLY A 37GLN A 39TRP A 69MET A 70CYH A 205THR A 208VAL A 216PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.3A)1TA A 301 (-4.0A) | 0.92A | 3gn8B-5ufsA:40.5 | 3gn8B-5ufsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GN8_B_DEXB247_1 (GLUCOCORTICOIDRECEPTOR 2) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 12 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80MET A 115CYH A 205THR A 208VAL A 216PHE A 218 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.3A)1TA A 301 (-4.0A) | 0.43A | 3gn8B-5ufsA:40.5 | 3gn8B-5ufsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39VAL A 40ARG A 80MET A 115LEU A 201 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A) | 0.57A | 3h52A-5ufsA:26.8 | 3h52A-5ufsA:76.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | LEU A 32GLY A 36GLN A 39VAL A 40MET A 70ARG A 80MET A 115LEU A 201 | 1TA A 301 (-3.5A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A) | 0.58A | 3h52A-5ufsA:26.8 | 3h52A-5ufsA:76.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 10 | LEU A 32TRP A 69MET A 70MET A 73LEU A 201 | 1TA A 301 (-3.5A)None1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 ( 3.8A) | 0.85A | 3h52B-5ufsA:29.3 | 3h52B-5ufsA:76.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 10 | LEU A 35MET A 70MET A 73MET A 221LEU A 222 | 1TA A 301 ( 3.6A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A)NoneNone | 1.41A | 3h52B-5ufsA:29.3 | 3h52B-5ufsA:76.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | GLY A 36GLN A 39LEU A 77ARG A 80CYH A 112MET A 115ILE A 226 | 1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 ( 2.8A)None | 1.32A | 3h52B-5ufsA:29.3 | 3h52B-5ufsA:76.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 11 / 12 | GLY A 36GLY A 37GLN A 39VAL A 40LEU A 77ARG A 80MET A 108CYH A 112MET A 115CYH A 205ILE A 225 | 1TA A 301 (-2.9A)None1TA A 301 (-3.0A)None1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 ( 3.6A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A)None | 0.78A | 3h52B-5ufsA:29.3 | 3h52B-5ufsA:76.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | GLY A 37GLN A 39VAL A 40CYH A 205ILE A 225 | None1TA A 301 (-3.0A)None1TA A 301 (-3.6A)None | 1.09A | 3h52B-5ufsA:29.3 | 3h52B-5ufsA:76.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | MET A 29GLY A 36GLY A 37VAL A 40ARG A 80MET A 108CYH A 112ILE A 225 | 1TA A 301 ( 2.9A)1TA A 301 (-2.9A)NoneNone1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 ( 3.6A)None | 0.90A | 3h52B-5ufsA:29.3 | 3h52B-5ufsA:76.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | GLY A 36GLN A 39VAL A 40TRP A 69MET A 70LEU A 77ARG A 80PHE A 92MET A 115 | 1TA A 301 (-2.9A)1TA A 301 (-3.0A)NoneNone1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 (-4.4A)1TA A 301 ( 2.8A) | 0.64A | 3h52C-5ufsA:27.3 | 3h52C-5ufsA:76.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | GLY A 36GLN A 39VAL A 40TRP A 69MET A 70LEU A 77MET A 108MET A 115 | 1TA A 301 (-2.9A)1TA A 301 (-3.0A)NoneNone1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 ( 3.0A)1TA A 301 ( 2.8A) | 1.06A | 3h52C-5ufsA:27.3 | 3h52C-5ufsA:76.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | GLY A 37GLN A 39VAL A 40TRP A 69MET A 70 | None1TA A 301 (-3.0A)NoneNone1TA A 301 ( 3.1A) | 0.96A | 3h52C-5ufsA:27.3 | 3h52C-5ufsA:76.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | LEU A 32GLY A 36GLN A 39VAL A 40TRP A 69MET A 70PHE A 92MET A 115 | 1TA A 301 (-3.5A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)NoneNone1TA A 301 ( 3.1A)1TA A 301 (-4.4A)1TA A 301 ( 2.8A) | 0.92A | 3h52C-5ufsA:27.3 | 3h52C-5ufsA:76.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | GLY A 36GLN A 39VAL A 40MET A 70LEU A 77ARG A 80MET A 108MET A 115CYH A 205 | 1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 ( 2.8A)1TA A 301 (-3.6A) | 0.89A | 3h52D-5ufsA:28.9 | 3h52D-5ufsA:76.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | GLY A 36GLN A 39VAL A 40MET A 70LEU A 77ARG A 80MET A 108MET A 115LEU A 201 | 1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A) | 0.71A | 3h52D-5ufsA:28.9 | 3h52D-5ufsA:76.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | GLY A 37GLN A 39VAL A 40MET A 70CYH A 205 | None1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.6A) | 1.23A | 3h52D-5ufsA:28.9 | 3h52D-5ufsA:76.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | MET A 29VAL A 40MET A 70MET A 108LEU A 201 | 1TA A 301 ( 2.9A)None1TA A 301 ( 3.1A)1TA A 301 ( 3.0A)1TA A 301 ( 3.8A) | 1.08A | 3h52D-5ufsA:28.9 | 3h52D-5ufsA:76.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HM1_B_J3ZB1_1 (ESTROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 11 | LEU A 32LEU A 35LEU A 77ARG A 80MET A 108 | 1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A) | 0.84A | 3hm1B-5ufsA:28.3 | 3hm1B-5ufsA:30.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HM1_B_J3ZB1_1 (ESTROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 11 | MET A 29LEU A 35LEU A 77ARG A 80MET A 108 | 1TA A 301 ( 2.9A)1TA A 301 ( 3.6A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A) | 1.20A | 3hm1B-5ufsA:28.3 | 3hm1B-5ufsA:30.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 11 / 12 | MET A 29ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80MET A 115LEU A 201THR A 208PHE A 218 | 1TA A 301 ( 2.9A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.53A | 3mneA-5ufsA:37.4 | 3mneA-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNE_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | MET A 29ASN A 33GLY A 37TRP A 69MET A 70THR A 208PHE A 218 | 1TA A 301 ( 2.9A)1TA A 301 (-3.0A)NoneNone1TA A 301 ( 3.1A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.90A | 3mneA-5ufsA:37.4 | 3mneA-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 10 / 12 | ASN A 33GLY A 36GLN A 39MET A 70ARG A 80MET A 115LEU A 201CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.66A | 3mnoA-5ufsA:38.1 | 3mnoA-5ufsA:76.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.86A | 3mnoA-5ufsA:38.1 | 3mnoA-5ufsA:76.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNO_A_DEXA784_2 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 4 / 6 | MET A 29LEU A 32TRP A 69MET A 73 | 1TA A 301 ( 2.9A)1TA A 301 (-3.5A)None1TA A 301 (-4.2A) | 0.14A | 3mnoA-5ufsA:38.1 | 3mnoA-5ufsA:76.38 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | ASN A 33GLY A 36GLN A 39MET A 70ARG A 80LEU A 201CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.32A | 3mnpA-5ufsA:38.6 | 3mnpA-5ufsA:75.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | ASN A 33GLY A 37MET A 70CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.87A | 3mnpA-5ufsA:38.6 | 3mnpA-5ufsA:75.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | GLY A 36GLN A 39MET A 70ARG A 80MET A 115LEU A 201CYH A 205THR A 208 | 1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A) | 0.72A | 3mnpA-5ufsA:38.6 | 3mnpA-5ufsA:75.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MNP_A_DEXA784_2 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 4 / 6 | MET A 29LEU A 32TRP A 69MET A 73 | 1TA A 301 ( 2.9A)1TA A 301 (-3.5A)None1TA A 301 (-4.2A) | 0.18A | 3mnpA-5ufsA:38.6 | 3mnpA-5ufsA:75.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OLL_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 10 | LEU A 32LEU A 35MET A 70LEU A 77ARG A 80 | 1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A) | 0.45A | 3ollA-5ufsA:28.1 | 3ollA-5ufsA:31.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OLL_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 10 | MET A 29LEU A 35MET A 70LEU A 77ARG A 80 | 1TA A 301 ( 2.9A)1TA A 301 ( 3.6A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A) | 0.68A | 3ollA-5ufsA:28.1 | 3ollA-5ufsA:31.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OLS_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | LEU A 32LEU A 35MET A 70LEU A 77ARG A 80 | 1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A) | 0.47A | 3olsA-5ufsA:29.2 | 3olsA-5ufsA:31.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VHU_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | ASN A 33GLN A 39LEU A 77ARG A 80MET A 108THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-3.0A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.04A | 3vhuA-5ufsA:36.7 | 3vhuA-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VHU_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | ASN A 33GLN A 39MET A 70LEU A 77ARG A 80LEU A 201CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.38A | 3vhuA-5ufsA:36.7 | 3vhuA-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VHU_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33LEU A 90CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.16A | 3vhuA-5ufsA:36.7 | 3vhuA-5ufsA:59.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ZQT_A_TESA1000_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | LEU A 32ASN A 33LEU A 35MET A 70MET A 73ARG A 80 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A) | 0.87A | 3zqtA-5ufsA:35.5 | 3zqtA-5ufsA:54.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ZQT_A_TESA1000_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | LEU A 35GLN A 39MET A 70MET A 73ARG A 80 | 1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A) | 0.97A | 3zqtA-5ufsA:35.5 | 3zqtA-5ufsA:54.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FN9_A_STRA301_1 (STEROID RECEPTOR 2) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39ARG A 80MET A 108THR A 208 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 (-3.0A) | 0.87A | 4fn9A-5ufsA:38.0 | 4fn9A-5ufsA:73.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FN9_A_STRA301_1 (STEROID RECEPTOR 2) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ALA A 74ARG A 80CYH A 205THR A 208 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.7A)1TA A 301 (-3.5A)1TA A 301 (-3.6A)1TA A 301 (-3.0A) | 0.49A | 4fn9A-5ufsA:38.0 | 4fn9A-5ufsA:73.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FN9_B_STRB301_1 (STEROID RECEPTOR 2) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39ARG A 80MET A 108THR A 208 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 (-3.0A) | 1.02A | 4fn9B-5ufsA:38.0 | 4fn9B-5ufsA:73.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FN9_B_STRB301_1 (STEROID RECEPTOR 2) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39TRP A 69MET A 70ARG A 80THR A 208 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 (-3.0A) | 0.48A | 4fn9B-5ufsA:38.0 | 4fn9B-5ufsA:73.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HLW_A_TESA1001_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | ASN A 33GLY A 37GLN A 39TRP A 69MET A 70MET A 73 | 1TA A 301 (-3.0A)None1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-4.2A) | 1.36A | 4hlwA-5ufsA:35.2 | 4hlwA-5ufsA:54.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HLW_A_TESA1001_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39TRP A 69MET A 70MET A 73ARG A 80 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A) | 0.83A | 4hlwA-5ufsA:35.2 | 4hlwA-5ufsA:54.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4J24_A_ESTA600_1 (ESTROGEN RECEPTORBETA) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | LEU A 32LEU A 35MET A 70LEU A 77ARG A 80 | 1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A) | 0.51A | 4j24A-5ufsA:29.2 | 4j24A-5ufsA:31.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_STRA301_1 (ANCESTRAL STEROIDRECEPTOR 2) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39ARG A 80MET A 108 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A) | 0.88A | 4ltwA-5ufsA:38.4 | 4ltwA-5ufsA:73.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_STRA301_1 (ANCESTRAL STEROIDRECEPTOR 2) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | LEU A 32ASN A 33LEU A 35GLN A 39MET A 70ARG A 80LEU A 201CYH A 205 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A) | 0.46A | 4ltwA-5ufsA:38.4 | 4ltwA-5ufsA:73.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_STRA301_2 (ANCESTRAL STEROIDRECEPTOR 2) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 8 | TRP A 69ALA A 74MET A 115PHE A 204THR A 208VAL A 216PHE A 218 | None1TA A 301 ( 3.7A)1TA A 301 ( 2.8A)1TA A 301 (-3.7A)1TA A 301 (-3.0A)1TA A 301 (-4.3A)1TA A 301 (-4.0A) | 0.62A | 4ltwA-5ufsA:38.4 | 4ltwA-5ufsA:73.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LTW_A_STRA301_2 (ANCESTRAL STEROIDRECEPTOR 2) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 8 | TRP A 69MET A 73ALA A 74MET A 115THR A 208VAL A 216PHE A 218 | None1TA A 301 (-4.2A)1TA A 301 ( 3.7A)1TA A 301 ( 2.8A)1TA A 301 (-3.0A)1TA A 301 (-4.3A)1TA A 301 (-4.0A) | 0.68A | 4ltwA-5ufsA:38.4 | 4ltwA-5ufsA:73.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OJB_A_198A1001_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | LEU A 35GLY A 36GLN A 39MET A 70ARG A 80 | 1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A) | 0.58A | 4ojbA-5ufsA:34.5 | 4ojbA-5ufsA:54.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OJB_A_198A1001_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | LEU A 35GLY A 36GLN A 39MET A 73ARG A 80 | 1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 (-4.2A)1TA A 301 (-3.5A) | 0.88A | 4ojbA-5ufsA:34.5 | 4ojbA-5ufsA:54.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OJB_A_198A1001_2 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 4 / 7 | ASN A 33LEU A 201ILE A 225ILE A 226 | 1TA A 301 (-3.0A)1TA A 301 ( 3.8A)NoneNone | 0.59A | 4ojbA-5ufsA:34.5 | 4ojbA-5ufsA:54.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OK1_A_198A1001_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | GLY A 37GLN A 39MET A 70ARG A 80ILE A 226 | None1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)None | 1.04A | 4ok1A-5ufsA:35.0 | 4ok1A-5ufsA:54.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OK1_A_198A1001_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | LEU A 32LEU A 35GLY A 36GLN A 39MET A 70ARG A 80ILE A 226 | 1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)None | 0.76A | 4ok1A-5ufsA:35.0 | 4ok1A-5ufsA:54.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKB_A_198A1002_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | LEU A 35GLY A 36GLN A 39MET A 70ARG A 80ILE A 226 | 1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)None | 0.79A | 4okbA-5ufsA:34.3 | 4okbA-5ufsA:54.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKB_A_198A1002_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | LEU A 35GLY A 36GLN A 39MET A 73ARG A 80ILE A 226 | 1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 (-4.2A)1TA A 301 (-3.5A)None | 0.95A | 4okbA-5ufsA:34.3 | 4okbA-5ufsA:54.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKT_A_198A1001_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | GLY A 37GLN A 39MET A 70ARG A 80ILE A 226 | None1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)None | 1.04A | 4oktA-5ufsA:34.7 | 4oktA-5ufsA:54.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKT_A_198A1001_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | LEU A 32LEU A 35GLY A 36GLN A 39MET A 70ARG A 80MET A 115ILE A 226 | 1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)None | 0.85A | 4oktA-5ufsA:34.7 | 4oktA-5ufsA:54.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKW_A_198A1001_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | LEU A 35GLY A 36GLN A 39MET A 70ARG A 80ILE A 226 | 1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)None | 0.66A | 4okwA-5ufsA:34.4 | 4okwA-5ufsA:54.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKW_A_198A1001_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | LEU A 35GLY A 36GLN A 39MET A 73ARG A 80ILE A 226 | 1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 (-4.2A)1TA A 301 (-3.5A)None | 0.84A | 4okwA-5ufsA:34.4 | 4okwA-5ufsA:54.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKX_A_198A1002_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | LEU A 35GLY A 36GLN A 39MET A 70ARG A 80 | 1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A) | 0.58A | 4okxA-5ufsA:34.5 | 4okxA-5ufsA:54.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OKX_A_198A1002_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | LEU A 35GLY A 36GLN A 39MET A 73ARG A 80 | 1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 (-4.2A)1TA A 301 (-3.5A) | 0.87A | 4okxA-5ufsA:34.5 | 4okxA-5ufsA:54.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OLM_A_198A1001_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | LEU A 32LEU A 35GLY A 36GLN A 39MET A 70ARG A 80 | 1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A) | 0.71A | 4olmA-5ufsA:34.0 | 4olmA-5ufsA:54.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OLM_A_198A1001_1 (ANDROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | LEU A 35GLY A 36GLN A 39MET A 73ARG A 80 | 1TA A 301 ( 3.6A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 (-4.2A)1TA A 301 (-3.5A) | 0.87A | 4olmA-5ufsA:34.0 | 4olmA-5ufsA:54.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_A_HCYA900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33GLY A 36LEU A 96THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-2.9A)None1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.43A | 4p6xA-5ufsA:38.2 | 4p6xA-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_A_HCYA900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33GLY A 37MET A 70THR A 208PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.95A | 4p6xA-5ufsA:38.2 | 4p6xA-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_A_HCYA900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | GLN A 39MET A 70LEU A 77ARG A 80GLN A 111 | 1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)None | 1.19A | 4p6xA-5ufsA:38.2 | 4p6xA-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_A_HCYA900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39MET A 70LEU A 77ARG A 80THR A 208PHE A 218 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.35A | 4p6xA-5ufsA:38.2 | 4p6xA-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_A_HCYA900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | MET A 29LEU A 32ASN A 33GLY A 36GLN A 39MET A 70ARG A 80THR A 208PHE A 218 | 1TA A 301 ( 2.9A)1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.49A | 4p6xA-5ufsA:38.2 | 4p6xA-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_C_HCYC900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 11 | MET A 29ASN A 33LEU A 35GLN A 39TRP A 69MET A 70MET A 73ARG A 80THR A 208 | 1TA A 301 ( 2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A)1TA A 301 (-3.0A) | 0.33A | 4p6xC-5ufsA:38.9 | 4p6xC-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_C_HCYC900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 11 | TRP A 69MET A 70MET A 73ARG A 80GLN A 111 | None1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 (-3.5A)None | 1.04A | 4p6xC-5ufsA:38.9 | 4p6xC-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_E_HCYE900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33GLY A 36LEU A 96THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-2.9A)None1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.42A | 4p6xE-5ufsA:38.3 | 4p6xE-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_E_HCYE900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33GLY A 37MET A 70THR A 208PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.95A | 4p6xE-5ufsA:38.3 | 4p6xE-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_E_HCYE900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 10 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39MET A 70MET A 73LEU A 77ARG A 80THR A 208PHE A 218 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.27A | 4p6xE-5ufsA:38.3 | 4p6xE-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_E_HCYE900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | MET A 70MET A 73LEU A 77ARG A 80GLN A 111 | 1TA A 301 ( 3.1A)1TA A 301 (-4.2A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)None | 1.11A | 4p6xE-5ufsA:38.3 | 4p6xE-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 10 / 12 | ASN A 33GLY A 36GLN A 39TRP A 69MET A 70LEU A 77ARG A 80MET A 115THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.44A | 4p6xG-5ufsA:38.8 | 4p6xG-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33GLY A 36LEU A 96THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-2.9A)None1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.42A | 4p6xG-5ufsA:38.8 | 4p6xG-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | ASN A 33GLY A 37TRP A 69MET A 70THR A 208PHE A 218 | 1TA A 301 (-3.0A)NoneNone1TA A 301 ( 3.1A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.89A | 4p6xG-5ufsA:38.8 | 4p6xG-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_G_HCYG900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | GLN A 39TRP A 69MET A 70LEU A 77ARG A 80GLN A 111MET A 115 | 1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)None1TA A 301 ( 2.8A) | 1.05A | 4p6xG-5ufsA:38.8 | 4p6xG-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33GLY A 36LEU A 96THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-2.9A)None1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.44A | 4p6xI-5ufsA:38.7 | 4p6xI-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | ASN A 33GLY A 37GLN A 39MET A 70THR A 208PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.12A | 4p6xI-5ufsA:38.7 | 4p6xI-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | GLN A 39MET A 70LEU A 77ARG A 80GLN A 111MET A 115 | 1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)None1TA A 301 ( 2.8A) | 1.17A | 4p6xI-5ufsA:38.7 | 4p6xI-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_I_HCYI900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 10 / 12 | LEU A 32ASN A 33GLY A 36GLN A 39MET A 70LEU A 77ARG A 80MET A 115THR A 208PHE A 218 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.45A | 4p6xI-5ufsA:38.7 | 4p6xI-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_K_HCYK900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80MET A 115THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.47A | 4p6xK-5ufsA:38.8 | 4p6xK-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_K_HCYK900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | ASN A 33GLY A 37TRP A 69MET A 70THR A 208PHE A 218 | 1TA A 301 (-3.0A)NoneNone1TA A 301 ( 3.1A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.90A | 4p6xK-5ufsA:38.8 | 4p6xK-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_K_HCYK900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | GLN A 39TRP A 69MET A 70ARG A 80GLN A 111MET A 115 | 1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.5A)None1TA A 301 ( 2.8A) | 1.17A | 4p6xK-5ufsA:38.8 | 4p6xK-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P6X_K_HCYK900_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | MET A 29ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80THR A 208PHE A 218 | 1TA A 301 ( 2.9A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.33A | 4p6xK-5ufsA:38.8 | 4p6xK-5ufsA:76.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | ASN A 33GLN A 39ARG A 80MET A 108PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 (-4.0A) | 0.89A | 4udaA-5ufsA:37.3 | 4udaA-5ufsA:62.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDA_A_DEXA1985_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 8 / 12 | ASN A 33GLN A 39MET A 70ARG A 80MET A 115LEU A 201CYH A 205PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A)1TA A 301 (-4.0A) | 0.36A | 4udaA-5ufsA:37.3 | 4udaA-5ufsA:62.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | ASN A 33GLY A 37TRP A 69MET A 70THR A 208PHE A 218 | 1TA A 301 (-3.0A)NoneNone1TA A 301 ( 3.1A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.92A | 4udcA-5ufsA:38.9 | 4udcA-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4UDC_A_DEXA1778_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 11 / 12 | MET A 29LEU A 32ASN A 33GLY A 36GLN A 39TRP A 69MET A 70ARG A 80MET A 115THR A 208PHE A 218 | 1TA A 301 ( 2.9A)1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 2.8A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.51A | 4udcA-5ufsA:38.9 | 4udcA-5ufsA:71.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XI3_C_29SC601_1 (ESTROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | LEU A 35TRP A 69LEU A 77ARG A 80MET A 108 | 1TA A 301 ( 3.6A)None1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A) | 0.67A | 4xi3C-5ufsA:24.8 | 4xi3C-5ufsA:30.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ZN7_A_DESA601_1 (ESTROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | MET A 29LEU A 32LEU A 77ARG A 80MET A 108 | 1TA A 301 ( 2.9A)1TA A 301 (-3.5A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A) | 1.21A | 4zn7A-5ufsA:28.1 | 4zn7A-5ufsA:30.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GS4_A_ESTA603_1 (ESTROGEN RECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | MET A 29LEU A 35LEU A 77ARG A 80MET A 108 | 1TA A 301 ( 2.9A)1TA A 301 ( 3.6A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A) | 0.85A | 5gs4A-5ufsA:27.0 | 5gs4A-5ufsA:30.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KSG_B_NIZB809_1 (CATALASE-PEROXIDASE) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 9 | ARG A 80VAL A 12GLY A 78SER A 81LEU A 77 | 1TA A 301 (-3.5A)NoneNoneNone1TA A 301 ( 3.4A) | 1.36A | 5ksgB-5ufsA:1.1 | 5ksgB-5ufsA:16.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KSN_A_NIZA809_1 (CATALASE-PEROXIDASE) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 9 | ARG A 80VAL A 12GLY A 78SER A 81LEU A 77 | 1TA A 301 (-3.5A)NoneNoneNone1TA A 301 ( 3.4A) | 1.36A | 5ksnA-5ufsA:0.6 | 5ksnA-5ufsA:16.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KSN_B_NIZB809_1 (CATALASE-PEROXIDASE) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 9 | ARG A 80VAL A 12GLY A 78SER A 81LEU A 77 | 1TA A 301 (-3.5A)NoneNoneNone1TA A 301 ( 3.4A) | 1.36A | 5ksnB-5ufsA:0.7 | 5ksnB-5ufsA:16.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KT8_B_NIZB809_1 (CATALASE-PEROXIDASE) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 9 | ARG A 80VAL A 12GLY A 78SER A 81LEU A 77 | 1TA A 301 (-3.5A)NoneNoneNone1TA A 301 ( 3.4A) | 1.35A | 5kt8B-5ufsA:0.3 | 5kt8B-5ufsA:16.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5MWY_A_YNUA1101_0 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | LEU A 32ASN A 33TRP A 69MET A 70LEU A 77LEU A 201 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)None1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 ( 3.8A) | 0.42A | 5mwyA-5ufsA:36.9 | 5mwyA-5ufsA:53.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5MWY_A_YNUA1101_0 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | TRP A 69MET A 70LEU A 77MET A 115LEU A 201 | None1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A) | 1.01A | 5mwyA-5ufsA:36.9 | 5mwyA-5ufsA:53.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5MWY_A_YNUA1101_1 (MINERALOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 6 | GLN A 39ARG A 80PHE A 92CYH A 205THR A 208PHE A 218 | 1TA A 301 (-3.0A)1TA A 301 (-3.5A)1TA A 301 (-4.4A)1TA A 301 (-3.6A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.32A | 5mwyA-5ufsA:36.9 | 5mwyA-5ufsA:53.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | ASN A 33GLY A 37GLN A 39MET A 70THR A 208PHE A 218 | 1TA A 301 (-3.0A)None1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 1.12A | 5nfpA-5ufsA:38.9 | 5nfpA-5ufsA:71.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | GLY A 36GLN A 39ARG A 80GLN A 111CYH A 112MET A 115 | 1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 (-3.5A)None1TA A 301 ( 3.6A)1TA A 301 ( 2.8A) | 1.35A | 5nfpA-5ufsA:38.9 | 5nfpA-5ufsA:71.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | GLY A 36GLN A 39MET A 70ARG A 80MET A 108CYH A 112MET A 115 | 1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 3.0A)1TA A 301 ( 3.6A)1TA A 301 ( 2.8A) | 0.83A | 5nfpA-5ufsA:38.9 | 5nfpA-5ufsA:71.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NFP_A_8W5A804_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 10 / 12 | MET A 29ASN A 33GLY A 36GLN A 39MET A 70ARG A 80CYH A 112MET A 115THR A 208PHE A 218 | 1TA A 301 ( 2.9A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 ( 3.1A)1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 ( 2.8A)1TA A 301 (-3.0A)1TA A 301 (-4.0A) | 0.45A | 5nfpA-5ufsA:38.9 | 5nfpA-5ufsA:71.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5SXS_B_NIZB806_1 (CATALASE-PEROXIDASE) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 9 | ARG A 80VAL A 12GLY A 78SER A 81LEU A 77 | 1TA A 301 (-3.5A)NoneNoneNone1TA A 301 ( 3.4A) | 1.35A | 5sxsB-5ufsA:0.2 | 5sxsB-5ufsA:16.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5SYI_B_NIZB805_1 (CATALASE-PEROXIDASE) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 9 | ARG A 80VAL A 12GLY A 78SER A 81LEU A 77 | 1TA A 301 (-3.5A)NoneNoneNone1TA A 301 ( 3.4A) | 1.35A | 5syiB-5ufsA:0.4 | 5syiB-5ufsA:16.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TOA_A_ESTA601_1 (ESTROGEN RECEPTORBETA) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | LEU A 32LEU A 35MET A 70LEU A 77ARG A 80 | 1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A) | 0.47A | 5toaA-5ufsA:26.4 | 5toaA-5ufsA:30.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5TOA_B_ESTB601_1 (ESTROGEN RECEPTORBETA) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 12 | MET A 29LEU A 35MET A 70LEU A 77ARG A 80 | 1TA A 301 ( 2.9A)1TA A 301 ( 3.6A)1TA A 301 ( 3.1A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A) | 0.71A | 5toaB-5ufsA:26.4 | 5toaB-5ufsA:30.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 11 / 12 | LEU A 32LEU A 35GLY A 36GLY A 37GLN A 39VAL A 40MET A 73LEU A 77ARG A 80CYH A 112MET A 115 | 1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 (-2.9A)None1TA A 301 (-3.0A)None1TA A 301 (-4.2A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 ( 2.8A) | 0.67A | 5uc1A-5ufsA:25.7 | 5uc1A-5ufsA:76.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 11 / 12 | LEU A 35GLY A 36GLY A 37GLN A 39VAL A 40TRP A 69MET A 73LEU A 77ARG A 80CYH A 112MET A 115 | 1TA A 301 ( 3.6A)1TA A 301 (-2.9A)None1TA A 301 (-3.0A)NoneNone1TA A 301 (-4.2A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 ( 2.8A) | 0.85A | 5uc1A-5ufsA:25.7 | 5uc1A-5ufsA:76.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 12 / 12 | LEU A 32ASN A 33LEU A 35GLY A 36GLY A 37GLN A 39VAL A 40MET A 73LEU A 77ARG A 80CYH A 112MET A 115 | 1TA A 301 (-3.5A)1TA A 301 (-3.0A)1TA A 301 ( 3.6A)1TA A 301 (-2.9A)None1TA A 301 (-3.0A)None1TA A 301 (-4.2A)1TA A 301 ( 3.4A)1TA A 301 (-3.5A)1TA A 301 ( 3.6A)1TA A 301 ( 2.8A) | 0.71A | 5uc1B-5ufsA:25.8 | 5uc1B-5ufsA:76.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 9 / 12 | ASN A 33GLY A 36GLN A 39MET A 73ARG A 80PHE A 92MET A 108MET A 115LEU A 201 | 1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)1TA A 301 (-4.2A)1TA A 301 (-3.5A)1TA A 301 (-4.4A)1TA A 301 ( 3.0A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A) | 0.62A | 5uc3A-5ufsA:33.2 | 5uc3A-5ufsA:75.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 10 / 12 | ASN A 33GLY A 36GLN A 39TRP A 69ARG A 80PHE A 92MET A 108MET A 115LEU A 201CYH A 205 | 1TA A 301 (-3.0A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)None1TA A 301 (-3.5A)1TA A 301 (-4.4A)1TA A 301 ( 3.0A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A) | 0.72A | 5uc3A-5ufsA:33.2 | 5uc3A-5ufsA:75.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 7 / 12 | MET A 29ASN A 33GLY A 36TRP A 69MET A 108LEU A 201CYH A 205 | 1TA A 301 ( 2.9A)1TA A 301 (-3.0A)1TA A 301 (-2.9A)None1TA A 301 ( 3.0A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A) | 1.11A | 5uc3A-5ufsA:33.2 | 5uc3A-5ufsA:75.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 10 / 12 | LEU A 32GLY A 36GLN A 39VAL A 40TRP A 69ARG A 80PHE A 92MET A 115LEU A 201CYH A 205 | 1TA A 301 (-3.5A)1TA A 301 (-2.9A)1TA A 301 (-3.0A)NoneNone1TA A 301 (-3.5A)1TA A 301 (-4.4A)1TA A 301 ( 2.8A)1TA A 301 ( 3.8A)1TA A 301 (-3.6A) | 0.53A | 5uc3B-5ufsA:33.0 | 5uc3B-5ufsA:75.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | MET A 29GLY A 36VAL A 40TRP A 69LEU A 201CYH A 205 | 1TA A 301 ( 2.9A)1TA A 301 (-2.9A)NoneNone1TA A 301 ( 3.8A)1TA A 301 (-3.6A) | 0.97A | 5uc3B-5ufsA:33.0 | 5uc3B-5ufsA:75.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 6 / 12 | VAL A 40TRP A 69ARG A 80GLN A 111MET A 115CYH A 205 | NoneNone1TA A 301 (-3.5A)None1TA A 301 ( 2.8A)1TA A 301 (-3.6A) | 1.46A | 5uc3B-5ufsA:33.0 | 5uc3B-5ufsA:75.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CDQ_A_NIZA809_1 (CATALASE-PEROXIDASE) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 9 | ARG A 80VAL A 12GLY A 78SER A 81LEU A 77 | 1TA A 301 (-3.5A)NoneNoneNone1TA A 301 ( 3.4A) | 1.40A | 6cdqA-5ufsA:undetectable | 6cdqA-5ufsA:17.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CDQ_B_NIZB808_1 (CATALASE-PEROXIDASE) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 9 | ARG A 80VAL A 12GLY A 78SER A 81LEU A 77 | 1TA A 301 (-3.5A)NoneNoneNone1TA A 301 ( 3.4A) | 1.38A | 6cdqB-5ufsA:0.6 | 6cdqB-5ufsA:17.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CFQ_B_NIZB809_1 (CATALASE-PEROXIDASE) |
5ufs | ANCESTRALGLUCOCORTICOIDRECEPTOR2 (unidentified) | 5 / 9 | ARG A 80VAL A 12GLY A 78SER A 81LEU A 77 | 1TA A 301 (-3.5A)NoneNoneNone1TA A 301 ( 3.4A) | 1.36A | 6cfqB-5ufsA:0.3 | 6cfqB-5ufsA:17.27 |